ABSTRACT: To identify the molecular pathophysiology present in early post-traumatic osteoarthritis (PTOA), the transcriptional profile of articular cartilage and its response to surgical PTOA induction were determined. Thirty six Yucatan minipigs underwent anterior cruciate ligament (ACL) transection and were randomly assigned in equal numbers to no further treatment, reconstruction or ligament repair. Cartilage was harvested at 1 and 4 weeks post-operatively and histology and RNA-sequencing were performed and compared to controls. Microscopic cartilage scores significantly worsened at 1 (p ¼ 0.028) and 4 weeks (p ¼ 0.001) post-surgery relative to controls, but did not differ between untreated, reconstruction or repair groups. Gene expression after ACL reconstruction and ACL transection were similar, with only 0.03% (including SERPINB7 and CR2) and 0.2% of transcripts (including INHBA) differentially expressed at 1 and 4 weeks respectively. COL2A1, COMP, SPARC, CHAD, and EF1ALPHA were the most highly expressed non ribosomal, non mitochondrial genes in the controls and remained abundant after surgery. A total of 1,275 genes were differentially expressed between 1 and 4 weeks post-surgery. With the treatment groups pooled, 682 genes were differentially expressed at both time-points, with the most significant changes observed in MMP1, COCH, POSTN, CYTL1, and PTGFR. This study confirmed the development of a microscopic PTOA stage after ACL surgery in the porcine model. Upregulation of multiple proteases (including MMP1 and ADAMTS4) were found; however, the level of expression remained orders of magnitude below that of extracellular matrix protein-coding genes (including COL2A1 and ACAN). In summary, genes with established roles in PTOA as well as novel targets for specific intervention were identified. ß
Knee injuries drastically increase the risk of posttraumatic osteoarthritis (OA). 1, 2 In animal models, surgical ACL transection, 3, 4 even when followed by surgical treatment of the ACL tear, 4 has been used to reliably produce knee OA in a variety of species. 5 In animal models and human patients, it is currently believed that ACL disruption initiates immediate molecular changes in the articular cartilage, which are followed by the development of structural disease and cartilage loss. 6, 7 The systematic profiling of the articular cartilage transcriptome in health and disease is a promising discovery approach to identify therapeutic targets. Hybridization-based methods (i.e., microarrays) and sequencing-based methods (i.e., RNA-sequencing [RNA-seq]) can be used to describe changes in transcriptome-wide gene expression between different conditions. However, RNA-seq has the unique ability to determine the relative expression levels of all genes within a cell or tissue. This technique has not yet been widely used on articular cartilage, [8] [9] [10] [11] [12] [13] [14] and to the best of our knowledge, the transcriptome-wide profile of articular cartilage obtained from healthy knee joints has not been reported.
In a physiologic state, chondrocytes synthesize large amounts of extracellular matrix proteins, including type II collagen, cartilage oligomeric matrix protein, and aggrecan core protein among others. 15 During OA development, the loss of the articular chondrocyte's phenotype, hypertrophy, and aberrant extracellular matrix remodeling are seen. 16 In later stage OA, extracellular matrix remodeling, in particular proteolytic degradation of type II collagen and aggrecan by Collagenase 3 or A disintegrin and metalloproteinase with thrombospondin motifs 5 among others (encoded by MMP13 or ADAMTS5, respectively), are established mechanisms resulting in structural damage. [17] [18] [19] Also in later stage OA, increased chondrocyte protease expression and subsequent matrix remodeling appear to mediate the association between complement system activation and structural cartilage damage. 20 These pathophysiologic mechanisms have been primarily identified using tissues harvested from patients with endstage osteoarthritis at joint replacement surgery, where areas with high degree of histopathological changes are compared to those presenting lower disease damage within the same joint. 14, 21, 22 However, it is likely that the disease-initiating molecular changes have already occurred in end-stage diseased joints, making the detection of early stage mechanisms challenging.
We postulated that differences in transcriptomewide gene expression in articular cartilage from healthy and recently injured knees would reveal novel target genes and pathways involved in early posttraumatic OA. In order to obtain control samples from healthy knee joints, we utilized a Yucatan minipig model, which has been previously shown to develop macroscopic cartilage features of post-traumatic OA within one year following ACL transection, even when the transection is treated with surgical reconstruction. 4 Human patients with ACL injury also exhibit the same pattern of cartilage degeneration (primarily in the medial femoral condyle) after ACL injury, also with or without ACL reconstruction. 5 Here, we utilized this preclinical model of post-traumatic OA in combination with RNA-seq to study the changes seen in the early post-surgical period, when little visible cartilage destruction is noted. We hypothesized that microscopic articular cartilage damage would develop on the medial femoral condyle within 1 month following surgical induction of OA with ACL surgery, and that concomitant changes in articular cartilage gene expression would also be present and provide insight as to the genes and pathways involved in the initiation of post-traumatic OA.
METHODS

Study Design
A controlled, large animal experiment with cross-sectional assessments at two post-surgery time points was designed. Approval of the Institutional Animal Care and Use Committee was obtained prior to performing this study. Forty-two adolescent Yucatan minipigs (Sinclair BioResources, Columbia, MO) were allocated to unilateral ACL transection surgery (n ¼ 36) or no surgery (INTACT, n ¼ 6). Animals receiving ACL transection surgery were allocated to euthanasia and outcome assessment at 1 week (1W, n ¼ 18) or 4 weeks (4W, n ¼ 18) after surgery. Within each time-point 6 of 18 animals were allocated to no treatment following transection, 6 of 18 to immediate ligament reconstruction surgery, and 6 of 18 to immediate ligament repair surgery. A computer based random permutation stratified for sex determined each animal's group allocation and side of unilateral surgery with an equal number of males and females in each group.
Microscopic damage of the medial femoral condyle cartilage (semiquantitative sum score according to Osteoarthritis Research Society International (OARSI) guidelines) 23 and site-matched transcriptome-wide gene expression levels were the primary outcomes, which were compared between the ACL surgery and intact control groups. Pathway enrichment analysis was used to identify functional relations between the differentially expressed genes. Secondary cartilage outcomes included the macroscopic scoring of all joint surfaces and the individual parameters of the microscopic OARSI sum score of the medial femoral condyle articular cartilage. 23 
Animal Model
While the animals were under anesthesia, a medial arthrotomy was performed and the fat pad partially resected to expose the ACL. The ACL was transected between the proximal and middle thirds of the ligament. A clinical exam was performed to verify complete ACL transection. In the animals assigned to receive ACL reconstruction surgery, a fresh-frozen bone-patellar-tendon-bone allograft, which was harvested from an age-, weight-, and sex-matched donor, was implanted as previously described. 4 In the animals assigned to ACL repair surgery, an extracellular matrix scaffold in combination with autologous blood was implanted as previously described. 4 Knees were thoroughly irrigated with 500 ml of normal saline following ACL transection in the group that did not receive further surgical treatment or following bone tunnel placement in those that received ACL reconstruction or repair. All incisions were closed in layers. No postoperative immobilization was used. Detailed information regarding animal husbandry and pain management are available in the supplemental methods (see Supplementary Methods).
Macroscopic Articular Cartilage Analysis
Upon harvest, the knee joints were opened using aseptic technique immediately after euthanasia. The macroscopic damage of the articular cartilage surfaces of the medial femoral condyle, medial tibial plateau, lateral femoral condyle, lateral tibial plateau, and femoral trochlea was scored according to OARSI guidelines for sheep and goat. 23 The ordinal scores ranged from 0 (i.e., normal) to 4 (i.e., large erosions down to subchondral bone). 23 Scores were recorded for each compartment, as well as macroscopic summary score from 0 to 20.
Articular Cartilage Sample Collection
Subsequently osteochondral samples were harvested from the medial femoral condyle for RNA isolation and histopathological analysis. The cartilage posterior to the frontal plane in the center of the medial femoral condyle was allocated to RNA isolation, while the cartilage immediately anterior of the central plane was allocated to histology. Biopsy punches of 5 mm diameter (Miltex, York, PA) were used to obtain 4-8 osteochondral biopsies from each animal. Osteochondral samples were rinsed in water and the cartilage was separated from the subchondral bone. Cartilage samples were immediately frozen in liquid nitrogen and stored at À80˚C until RNA isolation. Subsequently, frontal plane osteochondral slabs of 5 mm thickness were obtained just anterior to the RNA tissue at the center of the medial femoral condyle and immediately immersed in 10% neutral buffered formalin for later histological processing.
Sample Processing for Histopathology
Samples were fixed in 10% neutral buffered formalin for 48 h, followed by decalcification in 10% Formic acid (EMD Millipore, Darmstadt, Germany)/5% Formalin solution (Acros Organics, Belgium) for 10 days at room temperature on a shaker table. The solution was replaced every 48 h. Samples were dehydrated in 70%, 95%, and 100% Ethanol, 1:1 Ethanol/Xylene and 100% Xylene at room temperature for 24 h each, immersed in paraffin at 60˚C for 48 h and then embedded. 6 mm sections were mounted on silanized microscope slides (Superfrost Plus, Thermo Scientific, Waltham, MA) and stained with Safranin-O and Fast green. Staining and whole slide imaging was performed in one batch and with identical microscope settings.
Microscopic Articular Cartilage Analysis
Microscopic scoring of the medial femoral condyle articular cartilage was performed according to OARSI guidelines 23 by three independent experienced readers, blinded to the TRANSCRIPTIONAL PROFILING OF ARTICULAR CARTILAGE 319 experimental condition of the samples (BCF, KW, BLP). Examiner scores were averaged for analysis. Five individual parameters and their sum were assessed. The parameters included the interterritorial glycosaminoglycan-staining intensity (GAG score, ranging from 0-Normal to 4-No staining), chondrocyte density (0-Normal to 4-No cells), cell cloning (0-Normal to 4-Multiple cell nests or no cells in section) and structure (0-Normal to 10-Erosion or severe fibrillation to subchondral bone). Since Yucatan minipigs regularly display a penetration of vessels through the subchondral bone plate, the tidemark parameter was converted to a binary scale (0-Intact and 1-Penetration by vessels) and included in the sum of all parameters (Microscopic sum, 0-Normal to 23-Abnormal).
Articular Cartilage RNA-Seq Articular cartilage samples were homogenized using a sterile, nuclease free drill bit in 500 ml frozen TRIzol (Life Technologies) within a 2 ml tube (MP Biomedical) surrounded by liquid nitrogen. Following homogenization, 500 ml TRIzol was added and samples were brought to room temperature. Total RNA was then extracted by phenol-chloroform separation, and on-column purification using a PureLink RNA Mini Kit (Life Technologies). RNA samples were treated with DNase I (PureLink DNase Set; Life Technologies) and assessed for purity with a NanoDrop (Thermo scientific) and for integrity with an Agilent 2100 Bioanalyzer. The mean 260/280 absorbance ratios were 1.92, 1.97, and 2.01 for the INTACT, 1W, and 4W groups, respectively; the mean 260/230 ratios were 1.57, 1.75, and 1.50, and mean RNA integrity numbers (RINs) were 6.0, 7.0, and 7.4, respectively (Table 1; see Supplementary Table S1 for detailed information about RNA purity and integrity information for all groups). The samples were then enriched for poly(Aþ) messenger RNA, reverse transcribed with random hexamers, ligated with indexed adapters, and amplified with 17 cycles of polymerase chain reaction using a TruSeq RNA Sample Preparation Kit version 2 (Illumina). (Table 1; see  Supplementary Table S1 for number of reads and mapping information for all groups). Reads uniquely aligned to the exons of each gene were counted with a custom R script 25 that uses Rsamtools 26 and GenomicFeatures 27 packages. Reads per kilobase of transcript per million mapped reads (RPKM) were calculated for each transcript as a measure of transcript abundance in the cartilage samples. Differential expression and ontology term enrichment analyses were performed as described below. Transcriptome-wide gene expression data is available at ArrayExpress (E-MTAB-5879).
Statistical Analysis
Group-wise comparisons of macroscopic and microscopic outcomes were carried out in two iterations using the Kruskal-Wallis test, followed by Dunn's post-hoc test with Holm's p-value adjustment to correct for multiple comparisons. First, all possible combinations of factors, ACL status, post-surgery time and treatment, were compared (i.e., INTACT, 1W ACLT, 1W Reconstruction, 1W Repair, 4W ACLT, 4W Reconstruction and 4W Repair (n ¼ 6 in each group)). Second, groups defined by ACL status and postsurgery time only were compared with surgical treatments being pooled (INTACT n ¼ 6, 1W n ¼ 18, and 4W m ¼ 18). Adjusted p-values <0.05 were considered statistically significant.
Differential Expression Analysis
Differential expression analyses were performed using the edgeR package 28 in R version 3.2.3 (The R Foundation for Statistical Computing) by comparing the counts of reads uniquely aligned to exons between groups. p-values were adjusted for transcriptome-wide testing using the Benjamini and Hochberg method to represent the false discovery rate. 29 Adjusted p-values <0.05 were only considered significant when the expression levels were >1RPKM in at least one of the compared groups. To eliminate the risk of a single outlier producing a significant result, p-value and RPKM thresholds were required to be reproducibly met while each single sample was left out during replications of the tests.
Pathway Enrichment Analyses
The differentially expressed genes were used to analyze the enrichment of specific pathways using the Process Networks ontology in the MetaCore bioinformatics suite (Thomson Reuters). 30 Sus scrufa Ensembl identifiers and, if not recognized, gene symbols were used for the upload of the transcript lists. A similar list containing Ensembl identifiers and gene symbols of all 25,322 transcripts that could possibly be detected using our RNA-seq workflow was uploaded in an identical fashion and used as background list. Enrichment was considered significant when FDR <0.05.
RESULTS
There were no significant differences in baseline age, weight, and sex distribution between all groups (Table 1) . No adverse events were observed during surgery or follow-up.
Articular Cartilage Outcomes
At both post-surgery time points, there were no significant differences in any macroscopic or microscopic cartilage outcomes between groups with ligament reconstruction, repair surgery, or without additional treatment (see Supplementary Table S1 ). The results were thus pooled for each time-point.
The microscopic sum score increased significantly from the INTACT control to the 1W and 4W samples ( Table 1 ; Fig. 1 ). Among the secondary outcome measures, significantly increased GAG and tidemark scores (i.e., loss of glycosaminoglycans and penetration of the tidemark by vasculature) were observed at 1 and 4W post-surgery. Significantly increased chondrocyte density and cell cloning scores (i.e., increased presence of chondrocyte clusters) were only observed at 4W post-surgery (Table 1) .
Although there were no significant increases in macroscopic cartilage scores in the surgical animals, the 320 SIEKER ET AL. highest macroscopic scores were generally observed in the medial femoral condyle, which was expected based on previously performed long term investigations in the porcine model. 4 The medial compartment has also been shown to be the most affected after ACL reconstruction in humans. 5 These findings confirm the a priori selection of the medial femoral condyle articular cartilage for microscopic and transcriptomic analyses.
Transcriptional Profile of Healthy Articular Cartilage
A total of 11,432 out of 25,322 transcripts were expressed with an average !1 RPKM in the INTACT control group, the threshold set for relevant expression. RPKM values ranged over four orders of magnitude. The majority of transcripts were of low abundance (i.e., 7,583 transcripts expressed at 1 to 10 RPKM) or moderate abundance (i.e., 3,369 expressed at 10-100 RPKM), while fewer transcripts were of high abundance (i.e., 360 transcripts expressed at 100-1,000 RPKM and 120 transcripts expressed at >1,000 RPKM). Conversely, the 120 and 360 transcripts expressed at high abundance contributed 64.99% and 16.51% of the cumulative RPKMs, while moderate and low abundant transcripts contributed only 13.54% and 4.64%, respectively. The highest expression levels were detected for several non-protein coding genes, and genes encoding ribosomal, mitochondrial and typical cartilage matrix proteins, such as COL2A1, COL9A2, COL9A1, and COL11A2. The top abundant non mitochondrial, non ribosomal proteincoding transcripts are displayed in Table 2 (see  Supplementary Table S2 for the full transcriptional profiles of all groups).
Transcriptional Response of Articular Cartilage to ACL Surgery At 1W post-surgery, 552, 570, and 705 transcripts were differentially abundant in the comparison of ACLT, RECON, and REPAIR groups with the INTACT control group, while only seven transcripts were differentially abundant between RECON and ACLT group, and one transcript was differentially abundant between REPAIR and RECON group (Fig. 2B) . At 4W post-surgery, 947, 769, and 1,083 transcripts were differentially abundant in the comparison of ACLT, RECON, and REPAIR groups with the INTACT control group, while only 60 transcripts were differentially abundant between RECON and ACLT group, and 64 transcripts were differentially abundant between REPAIR and RECON group (Fig. 2B ). Since the majority of changes were observed due to ACL transection surgery independent of treatment, the results were thus pooled for each time-point for this report, however lists of all differentially expressed genes by treatment group are also provided (see Supplementary  Table S3 ).
With surgical treatment groups pooled, 12,018 and 12,960 out of 25,322 transcripts were expressed with averages !1 RPKM in the 1W and 4W post-surgery groups, respectively. The increase was significant for the 4W post-surgery time-point (see Table 1 ). In comparison to intact controls, 1,011 transcripts were differentially expressed at 1W post-surgery and 1,281 transcripts were differentially expressed at 4W postsurgery. While 329 and 599 transcripts were uniquely differentially expressed at 1W and 4W post-surgery, 682 transcripts were concordantly differentially expressed at both times (Fig. 2B) . Among the latter, the most drastic fold-changes were generally observed in transcripts that were not expressed at relevant levels in the healthy profile (i.e., <1 RPKM) or of low to moderate abundance, such as MMP1 which was expressed at 0.4 RPKM in intact controls, but upregulated by 804-and 375-fold at 1 and 4 weeks postsurgery. The exceptions to this included CYTL1, which was highly abundant in intact controls with a mean RPKM of 5,673 and downregulated to 0.10 and 0.07 of the intact control values at 1 and 4 weeks postsurgery. The 20 most significantly changed transcripts are shown in Table 3 (see Supplementary Table S3 for full list).
The 682 transcripts that were significantly differentially expressed at both post-surgery time-points enriched 16 pathways (process network ontology) including terms related to cell cycle, cytoskeleton, cell adhesion, chemotaxis, inflammation, immune response, proteolysis, and development pathways (Table  4 , Fig. 2D ).
Cell cycle_Mitosis was enriched by upregulated mitosis-promoting regulators Cyclin B1, Cyclin B2
and Cyclin-dependent kinase 1 (encoded by CCNB1, CCNB2, and CDK1), as well as kinetocore and spindle apparatus components such as Centromere-associated protein E, F, and Tubulin beta-3 chain (encoded by CENPE, CENPF, and TUBB3) among others.
The term Cytoskeleton_Spindle microtubules was enriched by similar genes as the above described cell cycle pathway.
Terms related to cell adhesion (including Cell adhesion_Cell-matrix interactions, Cell adhesion_Platelet-ednothelium-leucocyte interactions, Cell adhesion_ Glycoconjugates and Cell adhesion_Platelet aggregation) were enriched by various upregulated cell adhesion molecules. Among those, Cell adhesion_Cell-matrix interactions was most significantly enriched, due to increased expression of CD44 and Integrins a6 and b4 (encoded by CD44, ITGA6, and ITGB4) among others.
The Chemotaxis term was enriched by upregulations of several CC-chemokines including Monocyte chemotactic protein 1, Macrophage inflammatory protein 3 b and Macrophage inflammatory protein 3 (encoded by CCL2, CCL19, CCL23), CXC-chemokines including Chemokine BRAK and Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein (encoded by CXCL14 and CXCL16) and chemokine receptors including C-C chemokine receptor type 5 and Fractalkine receptor (CCR5 and CX3CR1).
Terms related to inflammation (including Inflammation_Complement system, Inflammation_Interferon signaling and Inflammation_MIF signaling) were significantly enriched. The Inflammation_Comple-ment system term was enriched most significantly, due to upregulated complement components (C1R, C2, C3, C7) and receptors (CR2, C5AR, C3AR) among others.
Terms related to proteolysis (including Proteolysis _ECM remodelling and Proteolysis_Connective tissue degradation) were enriched by upregulations of several matrix metalloproteinases including MMP-1, 3, 8, 13-15 (encoded by MMP1, MMP3, MMP8, MMP13, MMP14, and MMP15) and A disintegrin and metalloproteinase with thrombospondin motifs including ADAM-TS1, 4 and 9 (encoded by ADAMTS1, ADAMTS4, ADAMTS9).
The term Development_Blood vessel morphogenesis was significantly enriched as well. 
Transcriptional Changes in Articular Cartilage Between 1 and 4 Weeks Post-ACL Surgery
With the surgical treatment groups pooled, 1,275 transcripts were differentially expressed between the 4W and the 1W time-points (Fig. 2C) . Of those, 483 transcripts were also concordantly differentially expressed (i.e., same direction of regulation) in the comparison of the 4W and INTACT groups. The non ribosomal, non mitochondrial protein-coding genes that exhibited the greatest changes were TN-X, IFIT3, an AQP1 orthologue, PLTP, and SERPINE1, as well as several genes encoding uncharacterized proteins (all upregulated at 4W post-surgery). The changes also included an upregulation in COL10A1 and a downregulation of COMP among others (see Supplementary  Table S3 for full lists).
DISCUSSION
This study determined the transcriptional profile of articular cartilage from healthy knees and its early transcriptional response to surgical induction of OA. To our knowledge this is the first report to provide normative transcript abundance values, which provides context for previous and future gene expression studies of articular cartilage. We also confirmed our hypothesis that microscopic OA features and changes in the transcriptome-wide gene expression of articular cartilage would develop within 4 weeks after surgical induction of OA in the adolescent Yucatan minipigs. The confirmation was supported by a significant increase in the microscopic sum score of the medial femoral condyle at 1 and 4 weeks post-surgery, predominantly due to glycosaminoglycan loss ("GAG" sub score). While there was no significant progression of the microscopic structural damage ("Structure" sub score), a significant increase in chondrocyte clustering was observed between 1 and 4 weeks post-surgery ("Cell cloning" sub score). Although a protective effect of the ACL repair surgery technique is anticipated based on prior long-term studies in the porcine model with 12 months follow up, 4 no significant differences in cartilage integrity between the ACLT group and surgical reconstruction or repair groups were observed at 1 and 4 weeks. It is possible that the microscopic and macroscopic changes were either not present or too small to detect at these early time points. Despite extensive transcriptional changes and significant microscopic articular cartilage damage, no significant macroscopic cartilage damage was detected within the first 4 weeks following surgery. This is consistent with the current paradigm that an injury to the knee results in the onset of a molecular disease stage prior to developing macroscopic cartilage changes seen in later stage OA. 6 In looking at the pathophysiologic pathways that were significantly altered in the development of microscopic OA, several expected pathways were present. These included proteolysis (i.e., MMP13)
18,19 and the complement system pathway. 20 When examining the overall transcriptional profile for healthy cartilage, many of the most abundantly expressed transcripts for non ribosomal, non mitochondrial proteins encode structural extracellular matrix proteins, including genes coding for components of type II collagen, aggrecan, decorin, and biglycan. Interestingly, these genes remained in the group of most highly expressed transcripts after surgery, suggesting a large fraction of gene expression by the chondrocytes post-surgery remained devoted to anabolic function. While a few structural matrix proteins were significantly upregulated after induction of microscopic OA (FN1, LUM, and COL14A1), the enrichment of proteolysis pathways were primarily due to upregulation of genes encoding for proteolytic enzymes (ADAMTS4, MMP1, MMP3, MMP8, MMP13, MMP14, MMP15, PLAU, and PLAUR). While MMP1, MMP8, MMP13, MMP14, and ADAMTS4 have previously been found to play a role in OA, 31 MMP15 and PLAU and PLAUR have not, making them potentially novel targets for slowing proteolytic changes in the articular cartilage in the early days after injury. In this study, MMP1 was the most significantly upregulated gene in the cartilage at both 1 and 4 weeks following surgical induction of OA, with an 800 fold increase in expression. MMPs previously reported to play a significant role in later stage osteoarthritis (MMP2, MMP3, MMP13) had lesser increases, with two to fourfold increases in expression post-surgery. While all 20 of the ADAMTS family proteases have been previously identified in normal or arthritic cartilage, [32] [33] [34] only ADAMTS1, ADAMTS4, and ADAMTS9 were found to be significantly upregulated in this in vivo surgical OA induction model. However, even with the upregulation in protease gene expression, levels of gene expression for these molecules remained orders of magnitude below those seen for the major cartilage-related extracellular matrix proteins (i.e., at four weeks post-surgery, the gene expression for COL2A1 is 33,000 RPKM and for MMP1 is under 200 RPKM). These findings suggest that more of the machinery of the chondrocyte during the microscopic phase of post-traumatic OA is devoted to the production of anabolic rather than catabolic molecules.
The complement system has been previously identified to play a central role in OA in preclinical models 20 and human studies. 20, 35 In vitro studies suggest complement activation induces the expression of protease encoding genes (MMP1, MMP3, MMP13, ADAMTS4, ADAMTS5), 20 as well as proinflammatory genes (CSF1, CCL2, CCL5, PTGS2, C3, C5, and CFB).
20 Consistent with those in vitro studies, we found the expression of MMP1, MMP3, MMP13, ADAMTS4, CSF1, CCL2, PTGS2, and C3 to be upregulated in articular cartilage in vivo throughout the first month following knee-joint surgery. Using transcriptome-wide analyses allowed us to measure significant upregulation of gene expression of additional genes involved in the complement pathway, including C1R, C2, C3AR, C4BPA, C5AR, C7, CD55, CD93, CFI, and CR2, suggesting the upregulation of complement activity may involve more proteins than previously recognized.
In addition, several pathways, which have not previously been identified as having a role in the development of osteoarthritis, including the enrichment of terms related to cell cycle, cell adhesion and chemotaxis pathways, were shown to be active. Cell cycle-related ontology terms were mainly enriched by intracellular factors, such as mitosis promoting regulators and kinetocore and spindle apparatus components (i.e., CCNB1, CDK1, CENPE, TUBB3, and others). Cell adhesion-related terms, were enriched by upregulated proteases, but also by upregulated Integrin a6 and b4 subunits (encoded by ITGA6 and ITGB4). Previously, Integrin a6 expression was thought to be only present in cartilage during fetal development, 36 thus increased expression of ITGA6 following injury might represent the reactivation of fetal developmental processes. Chemotaxis related research in OA has mostly been focused on Monocyte chemoattractant protein 1 (encoded by CCL2), which has been detected in human articular chondrocytes from injured and osteoarthritic joints in vitro, 37 and
pharmacologic inhibition protected against cartilage damage following surgical knee injury in rats. 38 In this transcriptome-wide analysis, we detected an increased expression of CCL2 and several additional CC-chemokines and CXC-chemokine coding genes, including CCL8, CCL19, CCL23, CXCL14, and CXCL16. Those candidate genes are particularly attractive for further investigation, as the clinical safety Some limitations should be considered. In addition to p-value thresholds, only transcripts which were expressed >1 RPKM in at least one of the compared groups were declared as significantly changed to reduce false-positives. This threshold might exclude relevant transcripts, such as those encoding Interleukin-1 alpha (encoded by IL1A), which was upregulated by 20.3 and 19.7-fold at 1 and 4W post-surgery but only reached mean transcript abundance levels of 0.09 RPKM and was not considered significant. Thus, the pro-inflammatory mediators identified here are typically of higher abundance (i.e., chemokines), which should not lead to the conclusion that low abundance mediators (i.e., Interleukins) are irrelevant. Most genes presented here were leading the lists of differentially expressed genes, as ranked by p-value. The p-value in turn is typically related to the magnitude of fold-changes. However, it should not be anticipated that the extent of change in gene expression linearly translates to the change in biologic activity. Further, mechanisms driven by phosphorylation or localization changes (i.e., certain transcription factors) can only be predicted, not measured, in transcriptome-wide gene expression approaches. Traditionally, the effects of intraarticular bleeding, arthrotomy, and saline irrigation have been accounted for in animal studies by including a sham-surgery group in the experimental design. In the present study, the articular cartilage from the intact knees of healthy individuals served as the control group and no sham-surgery group (i.e., arthrotomy without ACL transection) was included. Therefore, a limitation of this study is that the effects of intraarticular bleeding, arthrotomy, saline irrigation, and the differences in knee biomechanics between groups could have contributed to the observed changes in cartilage integrity and gene expression. Although a study limitation, it was our intent to model the response of the whole joint due to ACL transection and ACL surgery. Thus, the gene expression changes described here only represent the response of articular cartilage to the surgically induced insult to the whole joint compared to normal joints. This response likely includes both, adaptive mechanisms and pathomechanisms of PTOA, which need to be delineated in further experiments. Nonetheless, these data are valuable for investigators evaluating candidate genes of interest in the immediate post-operative period. Additional experiments are required to further elucidate the isolated effects of the surgical incision. It should also be considered, that genes with changed expression throughout the early post-injury phase (i.e., differentially expressed at 1 and 4 weeks post-surgery when compared to intact controls) were prioritized for the identification of pathway-level alterations. The corresponding histopathological change in the articular cartilage was the loss of matrix GAGs, which was significant at 1 and 4 weeks post-surgery. It is likely that the GAG loss was also mediated by inflammationrelated molecules expressed in the synovium or present in the synovial fluid. Studies to assess the role of the synovium on cartilage health in this early postinjury period are currently underway. It should also be considered that adolescent animals, in which the tibial physis was not fully closed, were selected for this investigation. However, this skeletal maturity level translates to adolescent humans, which is the population at greatest risk for an ACL injury. 40 However, translation of the findings in adolescent animals to the adult situation should be performed with the appropriate caution.
The vast transcriptional response of articular cartilage to knee injury in a stage where only microscopic cartilage features of post-traumatic OA are detectable, supports the paradigm of an immediate onset of a molecular disease stage following injury, 6 and may provide unique insight into disease-initiating OA pathophysiology. We identified 682 candidate genes and 5 distinct pathways that were significantly changed in the development of early post-traumatic OA. Upregulation of genes coding for proteins with well-established roles in post-traumatic OA (i.e., CYTL1, MMP13) was noted, as well as upregulation of novel candidates for further investigation (i.e., ITGA6, ITGB4, CCL2, and several other chemokine coding genes). Most interestingly, while upregulation of multiple proteaseassociated genes was noted (including MMP1 and ADAMTS4), the level of expression of these genes remained orders of magnitude below those encoding for cartilage extracellular matrix proteins (including COL2A1, ACAN, and BGN), suggesting the chondrocytes remain in a primarily anabolic state after induction of the microscopic stage of osteoarthritis.
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